Emotion Induced Monoamine Neuromodulator Release Affects Functional Neurological Disorders

Area of Science:

• Neurology
• Psychiatry
• Neuroscience

Background:

• Functional neurologic disorders (FNDs) present diverse physical and psychological symptoms, mimicking other neurological conditions.
• Despite understanding emotional processes, a comprehensive understanding of emotional developmental variables in FND pathogenesis is lacking.
• Psychosocial adversity is a recognized risk factor for FND.

Purpose of the Study:

• To review recent advances in understanding the impact of emotional stress on FND.
• To examine the role of monoamine neuromodulators, such as norepinephrine and serotonin, in FND.
• To explore potential therapeutic targets and interventions for FND.

Main Methods:

• Literature review of recent experimental and theoretical emotion studies.
• Analysis of evidence linking psychosocial adversity to FND.
• Focus on the effects of monoamine neuromodulators on behavior.

Main Results:

• Recent emotion theories offer new perspectives on FND.
• Monoamine neuromodulators significantly influence behavior and may play a role in FND.
• Psychosocial factors are strongly associated with FND development.

Conclusions:

• Understanding emotional stress and neurochemical changes is crucial for clarifying FND pathogenesis.
• Monoamine neuromodulators represent potential therapeutic targets for FND.
• This review may inform future drug development and psychological interventions for FND.